Innovation is the essence of Ergobyte's corporate culture since its foundation. In parallel to commercial activities, research is jointly conducted with institutes, universities and other stakeholders. The results of this effort are integrated into existing products or become the seeds for new ones.
- Health knowledge representation
- Anonymization of health records
- Encryption and storage of sensitive information
- Clinical and administrative systems integration
- Manipulation, clustering and statistics
- Pattern recognition
Clinical decision support
- Computer-based medical diagnosis
- Machine learning and reasoning
- Risk assessment and diagnostics
- Semantic Web technologies
- E-prescription optimization
At Ergobyte, we are committed to make an impact that matters. The greatest payoff is to provide state-of-the-art solutions to the world that demonstrate that people's lives have been positively affected or even saved.
In September 2022, Ergobyte received the EHDEN certification for the provision of the following services: OHDSI Software and tools, OMOP CDM ETL, Technical infrastructure services, OMOP Standardized Vocabularies. The European Health Data and Evidence Network (EHDEN) focuses on the creation of an EU-wide ecosystem for federated analyses of real world data, standardized to the OMOP Common Data Model.
The team already works closely with EHDEN data partners in harmonizing their health data to the OMOP Common Data Model and contributing to EHDEN’s goal of maximizing the transformational potential of real world data to improve patient treatment and outcomes.
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 806968. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.